JP2022535956A5 - - Google Patents

Info

Publication number
JP2022535956A5
JP2022535956A5 JP2021573382A JP2021573382A JP2022535956A5 JP 2022535956 A5 JP2022535956 A5 JP 2022535956A5 JP 2021573382 A JP2021573382 A JP 2021573382A JP 2021573382 A JP2021573382 A JP 2021573382A JP 2022535956 A5 JP2022535956 A5 JP 2022535956A5
Authority
JP
Japan
Prior art keywords
alkyl
disease
compound
disorder
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021573382A
Other languages
English (en)
Japanese (ja)
Other versions
JP7682813B2 (ja
JP2022535956A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/066191 external-priority patent/WO2020249667A1/en
Publication of JP2022535956A publication Critical patent/JP2022535956A/ja
Publication of JP2022535956A5 publication Critical patent/JP2022535956A5/ja
Application granted granted Critical
Publication of JP7682813B2 publication Critical patent/JP7682813B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021573382A 2019-06-12 2020-06-11 スルホニル尿素誘導体及びその使用 Active JP7682813B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962860663P 2019-06-12 2019-06-12
US62/860,663 2019-06-12
PCT/EP2020/066191 WO2020249667A1 (en) 2019-06-12 2020-06-11 Sulfonylurea derivatives and uses thereof

Publications (3)

Publication Number Publication Date
JP2022535956A JP2022535956A (ja) 2022-08-10
JP2022535956A5 true JP2022535956A5 (cg-RX-API-DMAC7.html) 2023-06-19
JP7682813B2 JP7682813B2 (ja) 2025-05-26

Family

ID=71108563

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021573382A Active JP7682813B2 (ja) 2019-06-12 2020-06-11 スルホニル尿素誘導体及びその使用

Country Status (16)

Country Link
US (1) US12054461B2 (cg-RX-API-DMAC7.html)
EP (1) EP3983387B1 (cg-RX-API-DMAC7.html)
JP (1) JP7682813B2 (cg-RX-API-DMAC7.html)
CN (1) CN114641466B (cg-RX-API-DMAC7.html)
DK (1) DK3983387T3 (cg-RX-API-DMAC7.html)
ES (1) ES2983661T3 (cg-RX-API-DMAC7.html)
FI (1) FI3983387T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20240896T1 (cg-RX-API-DMAC7.html)
HU (1) HUE067378T2 (cg-RX-API-DMAC7.html)
LT (1) LT3983387T (cg-RX-API-DMAC7.html)
PL (1) PL3983387T3 (cg-RX-API-DMAC7.html)
PT (1) PT3983387T (cg-RX-API-DMAC7.html)
RS (1) RS65711B1 (cg-RX-API-DMAC7.html)
SI (1) SI3983387T1 (cg-RX-API-DMAC7.html)
SM (1) SMT202400291T1 (cg-RX-API-DMAC7.html)
WO (1) WO2020249667A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201721185D0 (en) 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
HUE067378T2 (hu) 2019-06-12 2024-10-28 Nodthera Ltd Szulfonilurea származékok és alkalmazásaik
JP7661248B2 (ja) 2019-06-12 2025-04-14 ノッドセラ リミテッド スルホニル尿素誘導体及びその使用
KR102802013B1 (ko) * 2021-02-03 2025-05-07 환인제약 주식회사 알츠하이머병 치료를 위한 nlrp3 인플라마좀 소분자 억제제

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2110689A (en) 1981-12-03 1983-06-22 Sandoz Ltd Herbicidal heterocyclic aminosulfonyl ureas and isoureas
CH649081A5 (de) 1982-01-12 1985-04-30 Ciba Geigy Ag Triaza-verbindungen.
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
JPS60214785A (ja) * 1984-03-27 1985-10-28 Nissan Chem Ind Ltd ピラゾ−ルスルホニルウレア誘導体、および植物生長調節剤または除草剤
US5214206A (en) 1990-11-07 1993-05-25 Warner-Lambert Company Aminosulfonyl urea acat inhibitors
CZ36394A3 (en) 1991-08-19 1994-07-13 Du Pont Substituted imidazilonone derivatives and pharmaceutical preparations based thereon
CZ36294A3 (en) 1991-08-19 1994-07-13 Du Pont Substituted imidazilonone derivatives and pharmaceutical preparations based thereon
NZ247440A (en) 1992-05-06 1995-04-27 Squibb & Sons Inc Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof
DE4217719A1 (de) * 1992-05-29 1993-12-02 Bayer Ag Zweifach heterocyclisch substituierte Sulfonylamino(thio)carbonylverbindungen
DE4302701A1 (de) 1993-02-01 1994-08-04 Bayer Ag Arylaminosulfonylharnstoffe
DE4302702A1 (de) 1993-02-01 1994-08-04 Bayer Ag Arylaminosulfonylharnstoffe
JP3355237B2 (ja) * 1993-10-15 2002-12-09 呉羽化学工業株式会社 N−(置換アミノ)ピロール誘導体、その製造方法及び除草剤
JPH0827147A (ja) * 1994-07-20 1996-01-30 Kureha Chem Ind Co Ltd N−(置換アミノ)イミド誘導体、その製造方法及び除草剤
JPH09132574A (ja) 1995-11-09 1997-05-20 Nissan Chem Ind Ltd フルオロプロピルチアゾリン誘導体の製造法
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
US6028201A (en) 1996-01-30 2000-02-22 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
AU3440597A (en) 1996-07-02 1998-01-21 Novartis Ag N-phenylimino heterocyclic derivatives and their use as herbicides
JPH1029990A (ja) 1996-07-12 1998-02-03 Kureha Chem Ind Co Ltd 1−(置換アミノ)イミダゾール誘導体、その製造方法及び除草剤
DE19651037A1 (de) 1996-12-09 1998-06-10 Bayer Ag Substituierte Thienyl(amino)sulfonyl(thio)harnstoffe
DK1270565T3 (da) 1997-01-29 2004-10-04 Pfizer 4-substitueret furan-2-sulfonamid og dets anvendelse i fremstillingen af sulfonylurinstofderivater
IT1290062B1 (it) 1997-03-13 1998-10-19 Isagro Ricerca Srl Amminosolfoniluree ad attivita' erbicida
GB9909409D0 (en) 1999-04-24 1999-06-23 Zeneca Ltd Chemical compounds
DE19937118A1 (de) 1999-08-06 2001-02-08 Bayer Ag Substituierte Thienyl(amino)sulfonylharnstoffe
JP4112127B2 (ja) 1999-08-31 2008-07-02 株式会社リコー 感熱記録材料
AU7447500A (en) 1999-09-30 2001-04-30 Mitsubishi Chemical Corporation Acylsulfonamide derivatives
US6593356B2 (en) 1999-10-20 2003-07-15 Bristol-Myers Squibb Pharma Company Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
EP1281399A3 (en) 2001-08-01 2004-02-11 Warner-Lambert Company Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production
WO2003029226A1 (en) 2001-09-26 2003-04-10 Basf Aktiengesellschaft Heterocyclyl substituted phenoxyalkyl-, phenylthioalkyl-, phenylaminoalkyl- and phenylalkyl-sulfamoylcarboxamides
US7144911B2 (en) 2002-12-31 2006-12-05 Deciphera Pharmaceuticals Llc Anti-inflammatory medicaments
US7279576B2 (en) 2002-12-31 2007-10-09 Deciphera Pharmaceuticals, Llc Anti-cancer medicaments
US7202257B2 (en) 2003-12-24 2007-04-10 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
US20070191336A1 (en) 2003-12-24 2007-08-16 Flynn Daniel L Anti-inflammatory medicaments
CA2592116A1 (en) 2004-12-23 2006-08-03 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
AU2008345225A1 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
US9271969B2 (en) 2012-02-07 2016-03-01 Kainos Medicine, Inc. Compounds as inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
CN103288750A (zh) 2013-03-04 2013-09-11 盐城工学院 新型氨基磺酰脲类化合物
US9410217B2 (en) 2014-02-18 2016-08-09 Renmatix, Inc. Method of reducing a fermentation and/or enzyme inhibitor in a saccharide-containing composition
JP6929792B2 (ja) 2015-02-16 2021-09-01 ザ ユニバーシティ オブ クィーンズランド スルホニル尿素及び関連化合物並びにその使用
BR112018016671A2 (pt) * 2016-02-16 2018-12-26 The University Of Queensland sulfonilureias e compostos relacionados e uso do mesmo
US10080743B2 (en) 2016-04-26 2018-09-25 Enanta Pharmaceuticals, Inc. Isoxazole derivatives as FXR agonists and methods of use thereof
US10080742B2 (en) 2016-04-26 2018-09-25 Enanta Pharmaceuticals, Inc. Isoxazole derivatives as FXR agonists and methods of use thereof
US10080741B2 (en) 2016-04-26 2018-09-25 Enanta Pharmaceuticals, Inc. Isoxazole derivatives as FXR agonists and methods of use thereof
US10144729B2 (en) 2016-05-18 2018-12-04 Enanta Pharmaceuticals, Inc. Isoxazole analogs as FXR agonists and methods of use thereof
WO2017201152A1 (en) 2016-05-18 2017-11-23 Enanta Pharmaceuticals, Inc. Isoxazole derivatives as fxr agonists and methods of use thereof
US10149835B2 (en) 2016-05-18 2018-12-11 Elmore Patent Law Group, P.C. Isoxazole derivatives as FXR agonists and methods of use thereof
EP3272739A1 (en) 2016-07-20 2018-01-24 NodThera Limited Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
JP7412328B2 (ja) 2017-07-24 2024-01-12 ノバルティス アーゲー Nlrp活性に関連する状態を治療するための化合物及び組成物
EP3668862A1 (en) 2017-08-15 2020-06-24 Inflazome Limited Novel sulfonamide carboxamide compounds
WO2019034697A1 (en) 2017-08-15 2019-02-21 Inflazome Limited NOVEL CARBOXAMIDE SULFONAMIDE COMPOUNDS
MX2020001776A (es) 2017-08-15 2020-03-24 Inflazome Ltd Sulfonilureas y sulfoniltioureas como inhibidores de nlrp3.
AU2018317800A1 (en) 2017-08-15 2020-02-13 Inflazome Limited Novel sulfonamide carboxamide compounds
TW201910314A (zh) 2017-08-15 2019-03-16 愛爾蘭商英弗雷佐姆有限公司 新穎化合物
TW201910317A (zh) 2017-08-15 2019-03-16 愛爾蘭商英弗雷佐姆有限公司 新穎化合物
WO2019034693A1 (en) 2017-08-15 2019-02-21 Inflazome Limited SULFONYLURATES AND SULFONYLTHIOURES AS INHIBITORS OF NLRP3
GB201721185D0 (en) 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
SG11202101480XA (en) * 2018-08-15 2021-03-30 Inflazome Ltd Novel sulfonamideurea compounds
GB201902327D0 (en) * 2019-02-20 2019-04-03 Inflazome Ltd Novel compounds
JP7661248B2 (ja) 2019-06-12 2025-04-14 ノッドセラ リミテッド スルホニル尿素誘導体及びその使用
HUE067378T2 (hu) 2019-06-12 2024-10-28 Nodthera Ltd Szulfonilurea származékok és alkalmazásaik
WO2020249669A1 (en) 2019-06-12 2020-12-17 NodThera Limited Sulfonamide derivatives and uses thereof
JP7865948B2 (ja) 2020-09-04 2026-05-26 ノッドセラ リミテッド アルキルオキサシクロアルキル部分を含むスルファモイル尿素誘導体およびその使用

Similar Documents

Publication Publication Date Title
JP2022536160A5 (cg-RX-API-DMAC7.html)
JP7738910B2 (ja) 置換ピリダジン化合物
JP2023540733A5 (cg-RX-API-DMAC7.html)
CN103347509B (zh) 用于治疗癌症的化合物和组合物
JP2020529405A5 (cg-RX-API-DMAC7.html)
JP2014513046A5 (cg-RX-API-DMAC7.html)
RS62164B1 (sr) Sulfoniluree i srodna jedinjenja i njihova upotreba
HRP20250964T1 (hr) Derivati sulfonil ureje kao modulatori nlrp3 inflamasoma
JP2021532124A (ja) Nlrp3インフラマソーム阻害剤
JP2021522276A5 (cg-RX-API-DMAC7.html)
JP2018531289A5 (cg-RX-API-DMAC7.html)
JP2022535955A5 (cg-RX-API-DMAC7.html)
JP2019533642A5 (cg-RX-API-DMAC7.html)
EP4168385A1 (en) Hydroxynorketamine analogues, compositions comprising same and methods of use thereof
JP7200005B2 (ja) 飽和環縮合ジヒドロピリミジノン又はジヒドロトリアジノン化合物及びその医薬用途
HRP20240896T1 (hr) Derivati sulfoniluree i njihova upotreba
JP2022522890A5 (cg-RX-API-DMAC7.html)
JP2022510587A5 (cg-RX-API-DMAC7.html)
WO2024177127A1 (ja) 置換ピラゾロピリミジン化合物及びその医薬用途
JP2022518526A5 (cg-RX-API-DMAC7.html)
JP7466520B2 (ja) 神経変性障害を治療するためのスルホプロパン酸誘導体
JP2025504374A5 (cg-RX-API-DMAC7.html)
TW201414707A (zh) 3,5,n-三羥烷醯胺及其衍生物、其之製造方法與用途
RU2023108168A (ru) Производные сульфамоилмочевины, содержащие алкилоксациклоалкильную группу, и их применения
WO2022184685A1 (en) Nicotinamide mononucleotide derivatives and use thereof for the treatment and/or prevention of long covid-19